Study of Tacrolimus Melt-Dose® for Lung Transplant Patients
NCT07042035 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2025-06-27
Summary
To evaluate, under usual clinical practice conditions and with a 12-month follow-up , the most relevant pharmacokinetic parameters of tacrolimus metabolism and safety, in patients with recent lung transplant (unilateral or bilateral) treated with LCPT.
Conditions
- Lung Trasplant
- Lung Transplantation
Sponsors & Collaborators
-
Trialance SCCL
collaborator INDUSTRY -
Chiesi España, S.A.U.
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-29
- Primary Completion
- 2026-10-29
- Completion
- 2026-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation
NCT00975663 ·Status: TERMINATED ·Phase: PHASE4
-
TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
NCT01564095 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression
NCT03800576 ·Status: COMPLETED
-
Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients
NCT02337036 ·Status: UNKNOWN ·Phase: NA
-
Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients
NCT01034345 ·Status: UNKNOWN ·Phase: PHASE2
-
An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
NCT05501574 ·Status: TERMINATED ·Phase: PHASE2
-
Tacrolimus Pharmacokinetic Subpopulations
NCT04526431 ·Status: RECRUITING
-
Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
NCT00608244 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.
NCT04102943 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
NCT00496483 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients
NCT01128335 ·Status: COMPLETED ·Phase: PHASE2
-
rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation
NCT01207141 ·Status: COMPLETED
-
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
NCT00297310 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation
NCT04360031 ·Status: UNKNOWN
-
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
NCT01387659 ·Status: TERMINATED ·Phase: NA
-
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
NCT01655563 ·Status: COMPLETED ·Phase: PHASE2
-
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence
NCT06960824 ·Status: NOT_YET_RECRUITING
-
Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
NCT01187953 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells
NCT03654794 ·Status: COMPLETED
-
Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance
NCT01445236 ·Status: TERMINATED ·Phase: NA
-
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
NCT06701825 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore
NCT04825262 ·Status: COMPLETED ·Phase: NA
-
Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.
NCT06147648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients
NCT06080490 ·Status: COMPLETED
-
Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
NCT00717379 ·Status: COMPLETED ·Phase: PHASE4